Discussion Topics
Target Audience
This activity is intended for hematologists, medical oncologists and other healthcare providers involved in the treatment of chronic myeloid leukemia.
Learning Objectives
Upon completion of this activity, participants should be able to
CE Credit
A CME credit link will be given to each participant as part of the meeting course materials.
Accreditation Statement
Research To Practice is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement
Research To Practice designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Unlabeled/Unapproved Uses Notice
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the provider or grantors.
Content Validation and Disclosures
Research To Practice (RTP) is committed to providing its participants with high-quality, unbiased and state-of-the-art education and adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of an accredited continuing education activity, including faculty, planners, reviewers and others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest will have been mitigated prior to the commencement of this activity. In addition, all activity content is reviewed by RTP scientific staff and an external, independent physician reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations.
FACULTY — The following faculty reported relevant financial relationships with ineligible entities:
Prof Hochhaus — Consulting Agreement: Novartis; Contracted Research: Enliven Therapeutics, Incyte Corporation, Novartis, Pfizer Inc, Terns Pharmaceuticals. Dr Smith — Consulting Agreements: Bristol Myers Squibb, Novartis, Pfizer Inc, Servier Pharmaceuticals LLC.
MODERATOR — Dr Mauro — Advisory Committees and Consulting Agreements: Bristol Myers Squibb, Enliven Therapeutics, Novartis, Takeda Pharmaceuticals USA Inc, Terns Pharmaceuticals; Contracted Research: Enliven Therapeutics, Novartis, Terns Pharmaceuticals, Sun Pharma Advanced Research Company (SPARC), Sun Pharmaceutical Industries Ltd.
Research To Practice CME Planning Committee Members, Staff and Reviewers — Planners, scientific staff and independent reviewers for Research To Practice have no relevant conflicts of interest to disclose. SupportersManchester Grand Hyatt San Diego
1 Market Place
San Diego, CA 92101
Meeting Room
Seaport A-D (Second Level)
I am a practicing physician, fellow, nurse or other healthcare provider involved in the treatment of cancer.
IN-PERSON RegistrationPlease note, a limited number of seats are available to other/industry professionals on a first come, first served basis.
IN-PERSON RegistrationPlease note, we will stream this event over Zoom. After registering you will receive a separate confirmation from Zoom with the viewing instructions.
REGISTRATION FOR WEBCAST »